Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T19:17:37.071Z.
Calculation as of: 2026-10-06T19:17:37.071Z.
Quote observation: 2026-10-06T19:15:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d441fe8f086afba93fb8397567d44bfe794a39cd606e17fb54204e4f45075d8b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
MIRA Pharmaceuticals, Inc.
Market Cap
$30.05M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.06M
Price/FCF Ratio
20.17
TTM Avg
16.64
3Y Avg
18.03
5Y Avg
18.03
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. (MIRA) | $30.05M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.06M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.46M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.66M | N/A | 4.39 | 4.39 | 4.39 |
| Context Therapeutics Inc. (CNTX)vs › | $29.85M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.67M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.49M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.71M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $31.06M | 20.17 | 16.64 | 18.03 | 18.03 |
| OneMedNet Corporation (ONMD)vs › | $28.82M | N/A | 2.82 | 2.82 | 2.82 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
